Amiodarone Infusion Dosing and Duration
For life-threatening arrhythmias, administer intravenous amiodarone as a 150 mg bolus over 10 minutes, followed by 1 mg/min infusion for 6 hours, then 0.5 mg/min for 18 hours, with a maximum total dose of 2.2 g over 24 hours. 1, 2, 3
Standard Dosing Protocol
The FDA-approved and guideline-recommended regimen delivers approximately 1000 mg over the first 24 hours:
Loading Phase:
- Initial bolus: 150 mg IV over 10 minutes
- Can repeat: Additional 150 mg bolus after 10-30 minutes if necessary for breakthrough arrhythmias 4
Maintenance Infusion:
- First 6 hours: 1 mg/min (360 mg total)
- Next 18 hours: 0.5 mg/min (540 mg total)
- Total 24-hour dose: Should not exceed 2.2 g 3
Clinical Context by Indication
Ventricular Tachycardia/Ventricular Fibrillation:
- Use the standard 150 mg bolus followed by infusion protocol 1, 5
- For cardiac arrest with shock-refractory VF/pVT, give 300 mg bolus initially, with possible second dose of 150 mg 5
- Onset of antiarrhythmic effect occurs within 30 minutes 4
Supraventricular Tachycardia/Atrial Fibrillation:
- Same dosing: 150 mg over 10 minutes, then standard infusion 2
- Rate control typically achieved within 1-6 hours 6, 7
- Rhythm conversion usually occurs after 6-8 hours if it occurs at all 8
Critical Administration Details
Infusion Requirements:
- Must use volumetric infusion pump (drop counters can underdose by up to 30%) 3
- Central venous catheter strongly preferred for concentrations >2 mg/mL 3
- Use in-line filter during administration 3
- Dilute in D5W only (not normal saline) 3
Concentration Limits:
- For peripheral IV: Maximum 2 mg/mL to minimize phlebitis risk 3
- For central line: Can use up to 6 mg/mL 3
- Infusions >2 hours must be in glass or polyolefin bottles 3
Supplemental Dosing for Breakthrough Arrhythmias
If hemodynamically unstable VT or VF recurs during maintenance infusion:
- Give 150 mg supplemental bolus over 10 minutes 3
- Mix in 100 mL D5W
- Can repeat as needed but monitor cumulative 24-hour dose 1
Duration of Therapy
Acute Phase:
- Maintenance infusion can continue for 2-3 weeks regardless of age, renal function, or left ventricular function 3
- Limited experience beyond 3 weeks of continuous IV therapy 3
Transition to Oral: When switching from IV to oral amiodarone, base the oral dose on duration of IV therapy 3:
- <1 week IV: Start 800-1600 mg/day oral
- 1-3 weeks IV: Start 600-800 mg/day oral
- >3 weeks IV: Start 400 mg/day oral
Common Pitfalls and Safety Considerations
Hypotension Risk:
- Most common adverse effect (26-36% of patients) 9, 10, 7
- Slow the infusion rate if hypotension develops
- No clear dose-response relationship for hypotension 9
- Never exceed 30 mg/min initial infusion rate 3
Bradycardia/AV Block:
- Monitor continuously during infusion 1, 2
- Contraindicated in second/third-degree AV block without pacemaker 2
Phlebitis:
- Occurs in 25% when given through peripheral vein 3
- Concentrations >3 mg/mL have high incidence of phlebitis 3
Hepatotoxicity Warning:
- Infusions at higher concentrations and faster rates than recommended have caused hepatocellular necrosis and acute renal failure leading to death 3
Drug Interactions:
- Increases INR with warfarin 2
- Contraindicated with dofetilide 2
- Avoid concurrent use with other QT-prolonging agents 1
The evidence consistently supports this standardized dosing approach across multiple high-quality guidelines from the AHA 1, 5, ACC/AHA/HRS 2, and FDA labeling 3, with research studies confirming efficacy and safety at these doses 9, 10.